EN
HI
Summary
As of 26 Aug, 2026, Genpharmasec stock price is ₹1.02. During the trading session, the stock has moved between an intraday low of ₹0.99 and an intraday high of ₹1.02. Over the last 52 weeks, Genpharmasec has traded between ₹0.75 and ₹2.15.
The stock has recorded a trading volume of 2,89,345 shares, with a market capitalization of ₹553719700. Its Average Traded Price (ATP) is ₹1.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1.02.
Genpharmasec has an upper circuit limit of ₹1.20 and a lower circuit limit of ₹0.80. The total value traded stands at ₹2.89 L, and the delivery percentage for the day is 82.5%.
The stock is currently traded with a market lot size of 1. Genpharmasec also offers a dividend yield of 0%.
Genpharmasec share price chart
Genpharmasec Share Key Metrics
Volume
2.89 L
Market Cap
55.37 CR
LTQ@LTP
2@1.02
ATP
1
Var Margin
25 %
Circuit Range
0.8-1.2
Delivery %
82.5 %
Value
2.89 L
ASM/GSM
No
Market Lot
1
Genpharmasec Fundamentals
P/E Ratio
0
P/B Ratio
0.84
Div. Yield
0
Sector P/E
61.08
Sector P/B
2.18
Sec. Div. Yield
75.6
Genpharmasec Resistance and Support
Pivot 0.98
Resistance
First Resistance
1.06
Second Resistance
1.11
Third Resistance
1.19
Support
First Support
0.93
Second Support
0.85
Third Support
0.8
Genpharmasec Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 1.02 | 1.02 | 2.00% | 1.02 | 0.99 |
| Tue Aug 25 2026 | 1.02 | 1 | -1.96% | 1.02 | 0.89 |
| Mon Aug 24 2026 | 1 | 1.02 | 2.00% | 1.02 | 0.99 |
Genpharmasec Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-09-02 | Others |
| 2025-08-07 | Quarterly Results |
| 2025-05-21 | Audited Results |
| 2025-03-24 | Independent Director Meeting |
| 2025-02-10 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Genpharmasec News
Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2026.
Genpharmasec confirmed no deviation in the use of proceeds from its Rights Issue for the quarter ended June 30, 2026. The company stated that the utilization of funds aligns with the objects mentioned in the Letter of Offer.
Aug 11 2026 16:21:15
Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, 11Th August, 2026.
Genpharmasec approved Q1 FY27 financial results. Consolidated revenue grew 312.76% YoY to ₹49.71 crores, but the company recorded a net loss of ₹0.17 crores compared to a net profit of ₹1.35 crores in Q1 FY26. Standalone results showed a net profit of ₹1.57 crores.
Aug 11 2026 16:02:46
Read More
Genpharmasec Management
| Name | Position |
|---|---|
| Sohan Chaturvedi | Whole Time Director & Chief Financial Officer |
| Rajesh Sadhwani | Non Independent & Non Executive Director |
Genpharmasec Similar Stocks
Sundaram Multi Pap Ltd.
1.24
0.01 (0.81%)
Trescon Ltd.
8.30
0.11 (1.34%)
Shree Krishna Paper Mills & Industries Ltd.
97.00
-3.00 (3.00%)
Diligent Media Corporation Ltd.
2.56
-0.06 (2.29%)
Franklin Industries Ltd.
0.33
0.01 (3.13%)
Starlog Enterprises Ltd.
38.13
-0.26 (0.68%)
Share Samadhan Ltd.
47.20
2.20 (4.89%)
Gabriel Pet Straps Ltd.
75.80
-0.04 (0.05%)
Balkrishna Paper Mills Ltd.
17.09
-0.18 (1.04%)
Genpharmasec FAQs
The Buying Price of Genpharmasec share is 1.02 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Genpharmasec stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Genpharmasec, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Genpharmasec shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Genpharmasec shares is 0.84. Useful to assess the stock's value relative to its book value.
To assess Genpharmasec’s valuation compare Sector P/E, P/B which are 61.08 & 2.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Genpharmasec is 55.37 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Genpharmasec share price is 2.15 & 0.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Genpharmasec belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
